Skip to main content
In stock | Hormonal Therapy

Seviteronel

Oncology Type Solid Tumour (Prostate)
Drug Class / Mechanism CYP17 / Androgen Synthesis Inhibitor
No Image
Description

Seviteronel is classified as a CYP17 / Androgen Synthesis Inhibitor, sourced for use within our Hormonal Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Hormonal Therapy
Oncology Type Solid Tumour (Prostate)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3